Microplate Handling System processes 50 plates/batch.October 10, 2006 -
Intended for SpectraMax Microplate Readers, StaxMax System fits in tight benchtop environments and enables researchers to run batches of microplates. It operates from within SoftMax® pro data analysis software, allowing researchers to have access to more than 120 assay protocols with complete data analysis in FDA 21 CFR Part 11 compliant environment.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Molecular Devices Corp.
1311 Orleans Dr.
Sunnyvale, CA, 94089-1136
USA
Molecular Devices Introduces StakMax Microplate Handling System for SpectraMax Microplate Readers
Molecular Devices Introduces StakMax Microplate Handling System for SpectraMax Microplate Readers
SUNNYVALE, Calif., Sept. 18 /- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced the introduction of StakMax(TM), an integrated microplate handling system for its SpectraMax(R) line of microplate readers. The StakMax system enables researchers to run batches of microplates, which increases productivity by requiring less hands- on time during experiments. StakMax will debut today at the Annual Meeting of the Society for Biomolecular Sciences (SBS) in Seattle, Washington, in Molecular Devices Booth #2501.
The StakMax system's small footprint makes it ideal for tight benchtop environments where automation is critical. The system can process up to 50 plates per batch and can be integrated with any Molecular Devices' SpectraMax reader sold today, as well as selected older readers. The new microplate handling system operates from within Molecular Devices' popular SoftMax(R) Pro microplate reader data analysis software, allowing researchers to have access to more than 120 assay protocols with complete data analysis. In addition, StakMax works with SoftMax Pro GxP to allow researchers to perform powerful data acquisition and analysis in a FDA 21 CFR Part 11 compliant environment.
Commenting on the launch, Evan Baxter, Product Marketing Manager at Molecular Devices, stated, "StakMax was developed to satisfy automation needs not addressed by available automation options. We received considerable feedback from SpectraMax customers looking for a simple, reliable automation system that was operable through SoftMax Pro software. StakMax was developed so that researchers could easily setup and run an assay without having automation expertise."
Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry to facilitate the high-throughput and cost-effective identification and evaluation of drug candidates. The Company's solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology and chemistry. Molecular Devices enables its customers to improve research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs.
CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533
Web site: http://www.moleculardevices.com/
|
|
|
|
|
|
|
| 
